drugset

drugset / Trial / NCT00719745

A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

NCT00719745 ↗

Phase 3 Completed 74 enrolled Astellas Pharma Inc Astellas Pharma Korea, Inc. · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate and to compare efficacy and safety of MR4 versus Prograf in patients undergoing primary liver transplantation.

Timeline

Start: 2006-02
Primary completion: 2008-06
Completion: 2008-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	—	Oral

Indications